← Home
The Peter Attia Drive · October 19, 2026 · 2h 4m

#412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, and the advances reshaping treatment | Siddhartha Mukherjee, M.D., Ph.D.

Siddhartha Mukherjee
Show Notes

Peter Attia talks with Siddhartha Mukherjee about the 15-year evolution of cancer science since The Emperor of All Maladies. They cover the roles of genetics, environment, random mutations, inflammation, and hyperinsulinemia in cancer risk; the challenges of CAR T therapy in solid tumors; KRAS inhibitors for pancreatic cancer; the rise of early-onset colorectal cancer; and the emerging concept of regenerative failure as a framework for aging. The conversation also touches on AI in drug discovery, chemorevention, and the quest for longevity biomarkers.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Preview

•
Hyperinsulinemia and Cancer Risk00:31:00
Mukherjee discusses the emerging role of hyperinsulinemia and metabolic dysregulation as contributors to cancer risk, alongside genetics, environment, and random mutations.
ClaudeChatGPTGemini
•
CAR T Cell Therapy and the Solid Tumor Barrier01:04:00
Despite revolutionizing blood cancer treatment, CAR T cell therapies remain largely ineffective against solid tumors because of the immunosuppressive tumor microenvironment and antigen heterogeneity.
ClaudeChatGPTGemini

3 more ideas, 1 references & all timestamps

This episode is in its early-access window. The full breakdown unlocks free in about 70 hours — Pro members read everything the moment it lands.

Read it now with Pro$10/mo · founding $96/yr
Was this useful?